Gabapentin
Product Images NDC 53002-5472

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 53002-5472). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Line graph depicting mean pain score over 8 weeks for Gabapentin 3600 mg/day versus placebo. The x-axis shows time in weeks, including a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis represents mean pain scores from 0 to 10, with scores decreasing more for Gabapentin compared to placebo.*

FDA Label Image

Figure 2 (Image 02)

Line graph depicting mean pain scores over 7 weeks during a clinical study comparing placebo with Gabapentin at doses of 1800 mg/day and 2400 mg/day. The x-axis shows weeks from baseline to week 7, and the y-axis shows mean pain scores from 0 to 10. The study includes a 3-week dose titration period followed by a 4-week fixed dose period, illustrating pain score trends for the three groups.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) at different doses in Study 1 and Study 2. The vertical axis shows percentage responders from 0% to 100%. Study 1 compares PBO (12%) to GBP 3600 mg (29%). Study 2 compares PBO (14%) to GBP 1800 mg (32%) and GBP 2400 mg (34%). Statistical significance is indicated with p-values less than 0.01 and 0.001.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

A formula chart depicting the calculation of creatinine clearance (CLCr). The formula uses variables including age in years, weight in kilograms, serum creatinine in mg/dL, and an adjustment factor (0.85) for female patients.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of Gabapentin, showing a cyclohexane ring attached to a side chain with amine (CH2NH2) and carboxylic acid (CH2CO2H) functional groups.*

FDA Label Image

Image-09 (Image 09)

A scatter plot chart showing the percentage difference versus daily dose (mg) with data points for three studies labeled a, b, and c. The x-axis represents daily dose in milligrams ranging from 600 to 1800 mg, and the y-axis shows difference percentage from 2% to 22%. The studies are represented by different symbols: study a (black squares), study b (gray squares), and study c (white squares).*

FDA Label Image

Label Image (Lbl530025472)

Gabapentin 100 mg capsules packaging label from RPK Pharmaceuticals, Inc. The label indicates a bottle containing 30 white, opaque capsules with instruction to take 1 capsule 3 times a day or as directed. The label includes prescription-only designation and placeholders for clinic name, patient information, and prescription details. The label features barcodes, NDC numbers, and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.